I 115th CONGRESS 1st Session H. R. 1223 IN THE HOUSE OF REPRESENTATIVES February 27, 2017 Mr. Bilirakis (for himself, Mr. Butterfield , and Mr. McCaul ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend the Federal Food, Drug, and Cosmetic Act to authorize an extension of exclusivity periods for certain drugs that are approved for a new indication for a rare disease or condition, and for other purposes.